Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280d87031f0c5786de1808713a1b76b7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
1995-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05d966675b8543680107a1cb2c0e85c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81cfb8613085f631e4004dcc3c762038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e892562b674a96b4d2132b4cec32567 |
publicationDate |
1996-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0695757-A2 |
titleOfInvention |
Human cancer inhibitory peptide amides |
abstract |
This application discloses seven newly synthesized pentapeptide amides and four tetrapeptide amides. The synthesis utilized both naturally occurring and modified amino acids; the modified amino acids are constituents of the well known dolastatin 10 and dolastatin 15 which are structurally distinct peptides with excellent antineoplastic activity. These peptides were constructed by introducing a peptide bond between selected amino acids and modified amino acids and coupling the resulting di- and tri-peptides to obtain peptides having a high anticancer activity against a series of human cancer cell lines. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7659241-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2353611-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004010957-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2357006-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6884869-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2747989-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000510-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10544218-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557780-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10808039-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829531-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10494432-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106674327-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906376-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414826-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318717-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107041139-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006128455-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7098308-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312748-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7851437-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7256257-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7745394-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703714-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE48558-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7423116-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981987-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2774989-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3149024-A4 |
priorityDate |
1994-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |